Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Bioorg Med Chem. 2012 Mar 1;20(5):1794-800. doi: 10.1016/j.bmc.2011.12.061. Epub 2012 Jan 9.
Microcin J25 (MccJ25) is a plasmid-encoded, ribosomally synthesized antibacterial peptide with a unique lasso structure. The lasso structure, produced with the aid of two processing enzymes, provides exceptional stability to MccJ25. We report the synthesis of six peptides (1-6), derived from the MccJ25 sequence, that are designed to form folded conformation by disulfide bond formation and electrostatic or hydrophobic interactions. Two peptides (1 and 6) display good activity against Salmonella newport, and are the first synthetic derivatives of MccJ25 that are bactericidal. Peptide 1 displays potent activity against several Salmonella strains including two MccJ25 resistant strains. The solution conformation and the stability studies of the active peptides suggest that they do not fold into a lasso conformation and peptide 1 displays antimicrobial activity by inhibition of target cell respiration. Like MccJ25, the synthetic MccJ25 derivatives display minimal toxicity to mammalian cells suggesting that these peptides act specifically on bacterial cells.
微菌素 J25(MccJ25)是一种质粒编码的核糖体合成的抗菌肽,具有独特的套索结构。套索结构在两种加工酶的辅助下产生,为 MccJ25 提供了非凡的稳定性。我们报告了六种肽(1-6)的合成,这些肽源自 MccJ25 序列,设计为通过二硫键形成和静电或疏水相互作用形成折叠构象。两种肽(1 和 6)对沙门氏菌新波特具有良好的活性,是 MccJ25 的第一个杀菌合成衍生物。肽 1 对包括两种 MccJ25 抗性菌株在内的几种沙门氏菌菌株显示出很强的活性。活性肽的溶液构象和稳定性研究表明,它们不会折叠成套索构象,肽 1 通过抑制靶细胞呼吸来显示抗菌活性。与 MccJ25 一样,合成的 MccJ25 衍生物对哺乳动物细胞的毒性最小,表明这些肽特异性作用于细菌细胞。